CA
NZ
UK
AU
IND
US
Crown PropTech Acquisitions filed a Form 8-K on November 6, 2026, disclosing that the SEC declared effective on November 4, 2026 the Form F-4 registration statement related to its proposed business combination with Mkango Rare Earths Limited, with mailing of the definitive proxy statement/prospectus …
Director Jennifer L. Hamann filed a Form 4 with the SEC on November 6, 2026, disclosing the acquisition of 79 deferred stock units in Steel Dynamics Inc. on November 5, 2026, in connection with her director retainer.
Steven John Mougis, Global Chief Communications Officer of DoubleVerify Holdings, Inc., filed a Form 4 on November 6, 2026, disclosing an acquisition of 802 shares of common stock on October 31, 2026, through the company's Employee Stock Purchase Plan.
Director Richard N. Massey of Alight, Inc. / Delaware filed a Form 4 on November 6, 2026, disclosing the sale of 25,000 shares of Class A Common Stock on November 5, 2026, at a weighted average price of $12.1071 per share.
Saba Capital Management, L.P. filed a Form 4 on November 6, 2026, disclosing a purchase of 7,747 shares of Ellsworth Growth & Income Fund Ltd common stock on November 5, 2026.
Kevin McCulloch, President and Chief Operating Officer of Xeris Biopharma Holdings, Inc., filed a Form 4 on November 6, 2026, disclosing the sale of 25,000 shares of common stock on November 5, 2026, pursuant to a Rule 10b5-1 trading plan.
General Motors Co Executive Vice President Rory Harvey filed a Form 4 on November 6, 2026, disclosing the sale of 16,513 shares of General Motors common stock on November 4, 2026, pursuant to a Rule 10b5-1 trading plan.
Ratnakar Lavu, Executive Vice President and Chief Digital Information Officer of Elevance Health, Inc. (NYSE:ELV), filed a Form 4 on November 6, 2026, disclosing the sale of 1,300 shares of common stock on November 5, 2026.
Michael Manning Collier, Executive Vice President at HealthStream Inc, filed a Form 4 on November 6, 2026, reporting transactions in HealthStream common stock and employee stock options dated November 5, 2026.
Boston Scientific Corp Chairman, President and CEO Michael F. Mahoney filed a Form 4 on November 6, 2026, disclosing two gift transactions dated November 4, 2026, involving the transfer of Boston Scientific common stock through two irrevocable trusts.
Please wait processing your request...